The following is a summary of “Association Between Patient Perception of Disease Status and Different Components of the ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed, according to a study recently published online in ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its ...

Scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream.

Professor Ed Rainger, University of Birmingham The study is part of a wider research programme on PEPITEM and its potential use in therapies for diseases such as rheumatoid arthritis (RA), diabetes, ...

Researchers conducted a retrospective cohort study of patients with psoriasis or psoriatic arthritis from Taiwan’s National Health Insurance Research Database during 2011-2021 who were treated ...

Ontario residents 66 years and older with psoriatic disease were identified, and 11,641 individuals who received their first systemic therapy between April, 2002, and January, 2021, were included.

Approximately 60% to 85% of patients who develop psoriatic arthritis will have first developed psoriasis. Blocking IL-23 may block other proinflammatory cytokines implicated in psoriasis.

Patients are taking part in a trial that scientists hope could ultimately lead to a cure for rheumatoid arthritis. The AuToDeCRA-2 study seeks to prove it is possible to train white blood cell ...

ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...